PSYCHOMETRIC VALIDATION OF THE ELECTRONIC HIDRADENITIS SUPPURATIVA (HS) SYMPTOM DAILY DIARY (EHSSDD) AND ELECTRONIC HS SYMPTOM QUESTIONNAIRE (EHSSQ) USING DATA FROM THE PHASE 3 BE HEARD TRIALS OF BIMEKIZUMAB IN HS

被引：0
|
作者：
Ingram, J. R. [1 ]
Kirby, J. [2 ]
Ciaravino, V [3 ]
Rolleri, R. [4 ]
Pansar, I [5 ]
Lambert, J. [3 ]
Muller, E. [6 ]
Pelligra, C. [7 ]
机构：
[1] Cardiff Univ, Cardiff, Wales
[2] Penn State Milton S Hershey Med Ctr, Hershey, PA USA
[3] UCB Pharma, Colombes, France
[4] UCB Pharma, Morrisville, NC USA
[5] UCB Pharma, Brussels, Belgium
[6] UCB Pharma, Slough, Berks, England
[7] Evidera, Medellin, Colombia
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
MSR15
引用
收藏
页码：S280 / S280
页数：1
相关论文
共 6 条
  • [1] PSYCHOMETRIC VALIDATION OF THE ELECTRONIC HIDRADENITIS SUPPURATIVA QUALITY OF LIFE (EHISQOL) QUESTIONNAIRE USING POOLED DATA FROM THE PHASE 3 BE HEARD TRIALS OF BIMEKIZUMAB IN HIDRADENITIS SUPPURATIVA
    Kirby, J.
    Ingram, J. R.
    Ciaravino, V
    Lambert, J.
    Rolleri, R.
    Pansar, I
    Mueller, E.
    Pelligra, C.
    VALUE IN HEALTH, 2023, 26 (06) : S289 - S289
  • [2] Content Validity, Acceptability, and Usability of the Electronic Hidradenitis Suppurativa Symptom Daily Diary and the Electronic Hidradenitis Suppurativa Symptom Questionnaire
    Ingram, J. R.
    Ciaravino, V
    Rolleri, R.
    Gillard, P.
    Pansar, I
    Taylor, N.
    Kirby, J. S.
    VALUE IN HEALTH, 2022, 25 (12) : S396 - S397
  • [3] Electronic Patient-Reported Outcomes in Hidradenitis Suppurativa: Content Validity and Usability of the Electronic Hidradenitis Suppurativa Symptom Daily Diary, Hidradenitis Suppurativa Symptom Questionnaire and Hidradenitis Suppurativa Quality of Life Questionnaire
    Ingram, John R.
    Ciaravino, Valerie
    Rolleri, Robert
    Pansar, Ingrid
    Dias-Barbosa, Carla
    Kirby, Joslyn
    DERMATOLOGY, 2024, 240 (01) : 65 - 76
  • [4] Hidradenitis Suppurativa Symptom Daily Diary (HSSDD) and Questionnaire (HSSQ): Psychometric Validation and Interpretation Threshold Derivation Using Phase 3 Study Data
    Ingram, John R.
    Lambert, Jeremy
    Ciaravino, Valerie
    Rolleri, Robert
    Pansar, Ingrid
    Peterson, Luke
    Pelligra, Christopher G.
    Thorlacius, Linnea
    DERMATOLOGY AND THERAPY, 2025, : 1093 - 1111
  • [5] Psychometric validation of the Psoriasis Symptom Diary using Phase III study data from patients with chronic plaque psoriasis
    Strober, Bruce
    Zhao, Yang
    Tran, Mary Helen
    Gnanasakthy, Ari
    Nyirady, Judit
    Papavassilis, Charis
    Nelson, Lauren M.
    McLeod, Lori D.
    Mordin, Margaret
    Gottlieb, Alice B.
    Elewski, Boni E.
    Lebwohl, Mark
    INTERNATIONAL JOURNAL OF DERMATOLOGY, 2016, 55 (03) : E147 - E155
  • [6] PSYCHOMETRIC ASSESSMENT OF THE PSORIATIC ARTHRITIS IMPACT OF DISEASE-12 (PSAID-12) QUESTIONNAIRE USING POOLED DATA FROM THE PHASE 3 BE OPTIMAL AND BE COMPLETE TRIALS OF BIMEKIZUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS
    Gossec, L.
    Coates, L. C.
    Orbai, A. M.
    Pelligra, C.
    Lambert, J.
    Ciaravino, V
    Ink, B.
    Taieb, V
    Gladman, D. D.
    VALUE IN HEALTH, 2023, 26 (06) : S323 - S323
1